5-78228244-TA-TAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_003664.5(AP3B1):​c.280-6dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.311 in 1,555,402 control chromosomes in the GnomAD database, including 67,140 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8529 hom., cov: 0)
Exomes 𝑓: 0.31 ( 58611 hom. )

Consequence

AP3B1
NM_003664.5 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.10

Publications

6 publications found
Variant links:
Genes affected
AP3B1 (HGNC:566): (adaptor related protein complex 3 subunit beta 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is part of the heterotetrameric AP-3 protein complex which interacts with the scaffolding protein clathrin. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2012]
AP3B1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 5-78228244-T-TA is Benign according to our data. Variant chr5-78228244-T-TA is described in ClinVar as Benign. ClinVar VariationId is 354253.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.333 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP3B1NM_003664.5 linkc.280-6dupT splice_region_variant, intron_variant Intron 3 of 26 ENST00000255194.11 NP_003655.3
AP3B1NM_001271769.2 linkc.133-6dupT splice_region_variant, intron_variant Intron 3 of 26 NP_001258698.1
AP3B1NM_001410752.1 linkc.280-6dupT splice_region_variant, intron_variant Intron 3 of 22 NP_001397681.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP3B1ENST00000255194.11 linkc.280-6_280-5insT splice_region_variant, intron_variant Intron 3 of 26 1 NM_003664.5 ENSP00000255194.7

Frequencies

GnomAD3 genomes
AF:
0.334
AC:
50595
AN:
151412
Hom.:
8523
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.332
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.304
Gnomad ASJ
AF:
0.396
Gnomad EAS
AF:
0.325
Gnomad SAS
AF:
0.282
Gnomad FIN
AF:
0.366
Gnomad MID
AF:
0.418
Gnomad NFE
AF:
0.337
Gnomad OTH
AF:
0.325
GnomAD2 exomes
AF:
0.309
AC:
69101
AN:
223498
AF XY:
0.311
show subpopulations
Gnomad AFR exome
AF:
0.318
Gnomad AMR exome
AF:
0.254
Gnomad ASJ exome
AF:
0.369
Gnomad EAS exome
AF:
0.310
Gnomad FIN exome
AF:
0.339
Gnomad NFE exome
AF:
0.322
Gnomad OTH exome
AF:
0.310
GnomAD4 exome
AF:
0.308
AC:
432770
AN:
1403874
Hom.:
58611
Cov.:
26
AF XY:
0.309
AC XY:
215933
AN XY:
699546
show subpopulations
African (AFR)
AF:
0.320
AC:
10189
AN:
31842
American (AMR)
AF:
0.251
AC:
10788
AN:
42988
Ashkenazi Jewish (ASJ)
AF:
0.372
AC:
9276
AN:
24964
East Asian (EAS)
AF:
0.298
AC:
11421
AN:
38286
South Asian (SAS)
AF:
0.272
AC:
22518
AN:
82764
European-Finnish (FIN)
AF:
0.329
AC:
15909
AN:
48420
Middle Eastern (MID)
AF:
0.394
AC:
2202
AN:
5594
European-Non Finnish (NFE)
AF:
0.310
AC:
332164
AN:
1070908
Other (OTH)
AF:
0.315
AC:
18303
AN:
58108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
12595
25191
37786
50382
62977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11022
22044
33066
44088
55110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.334
AC:
50634
AN:
151528
Hom.:
8529
Cov.:
0
AF XY:
0.332
AC XY:
24602
AN XY:
74018
show subpopulations
African (AFR)
AF:
0.332
AC:
13721
AN:
41270
American (AMR)
AF:
0.303
AC:
4612
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
1371
AN:
3462
East Asian (EAS)
AF:
0.326
AC:
1688
AN:
5180
South Asian (SAS)
AF:
0.280
AC:
1340
AN:
4786
European-Finnish (FIN)
AF:
0.366
AC:
3836
AN:
10478
Middle Eastern (MID)
AF:
0.429
AC:
126
AN:
294
European-Non Finnish (NFE)
AF:
0.337
AC:
22866
AN:
67840
Other (OTH)
AF:
0.323
AC:
679
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1679
3358
5037
6716
8395
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.250
Hom.:
761

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 52% of patients studied by a panel of primary immunodeficiencies. Number of patients: 50. Only high quality variants are reported.

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Feb 09, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hermansky-Pudlak syndrome 2 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Dec 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hermansky-Pudlak syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5868908; hg19: chr5-77524068; COSMIC: COSV54887195; API